Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Background: Bietti’s Crystalline Dystrophy is an uncommon autosomal recessive tapetoretinal dystrophy resulting from a mutation in the CYP4V2 gene. It is characterized by the presence of subepithelial corneal deposits at the limbus and small crystalline deposits in the posterior pole of the retina, accompanied by atrophy of the retinal pigment epithelium and choriocapillaris. Case report: In this report, we present the case of a 55-year-old male exhibiting reduced visual acuity, nyctalopia, impaired color vision, and yellow-white crystal deposition in the posterior pole of both eyes. Additionally, areas of retinal pigment epithelium atrophy and pigment clumping were observed. Spectral-domain optical coherence tomography (SD-OCT) of the macula revealed hyperreflective dots in the outer retinal layers, retinal pigment epithelium, and choroid, along with outer retinal tubulations. Electroretinography (ERG) results were subnormal, and visual field assessment indicated paracentral scotomas in both eyes. The patient has been prescribed spectacles and is undergoing regular follow-up. Conclusion: This case is highlighted due to its rarity and underscores the significance of employing SD-OCT and electrophysiological studies for early disease diagnosis. Additionally, it emphasizes the role of genetic counseling in preventing the inheritance of this condition.
Biettis dystrophy, Retinal dystrophy, crystalline retinopathy, tapetoretinal dystrophy, CYP4V2 mutation